| P50 | author | Sebastian Amigorena | Q37728726 |
| P2093 | author name string | Pascale Hubert | |
| P2860 | cites work | Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets | Q28140238 |
| | Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV. | Q36835221 |
| | Immune parameters affecting the efficacy of chemotherapeutic regimens | Q37848665 |
| | Antibody-dependent cell cytotoxicity synapses form in mice during tumor-specific antibody immunotherapy | Q39520030 |
| | Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice | Q39797630 |
| | Active specific immunotherapy of a murine mammary adenocarcinoma using a synthetic tumor-associated glycoconjugate. | Q41728009 |
| | In vivo cytotoxicity of type I CD20 antibodies critically depends on Fc receptor ITAM signaling. | Q46131685 |
| | T and Tn, general carcinoma autoantigens | Q71372455 |
| | Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene | Q77535970 |
| | Monoclonal antibody therapy of cancer | Q81189032 |
| P433 | issue | 1 | |
| P921 | main subject | antibody | Q79460 |
| | immunotherapy | Q1427096 |
| | cancer immunotherapy | Q2012719 |
| P304 | page(s) | 103-105 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | OncoImmunology | Q18026500 |
| P1476 | title | Antibody-dependent cell cytotoxicity in monoclonal antibody-mediated tumor immunotherapy | |
| P478 | volume | 1 | |